PD-L1 Antibodies
Your search for reliable PD-L1 antibodies ends here. PD-L1, known by aliases such as CD274, Cd274, PDCD1LG2, is an integral part of our antibody range. Whether you're working with Human, Mouse, Rat, Pig, Cow, or other species, our range of PD-L1 antibodies offer precise detection across diverse samples. These specialized antibodies are tailored for various scientific applications like WB, FACS, ELISA, IF (cc), IHC, providing you with options like polyclonal, recombinant, and monoclonal antibodies, sourced from different host species such as Rabbit, Mouse, Rat. The efficacy of our antibodies is well-established, demonstrated through multiple methods.
Detailed information, including references, images, and validations by other customers, can be found on each product page. Should you require assistance in finding a specific product, our customer service team is ready to assist. Utilize our PD-L1 antibodies in your research endeavors for dependable PD-L1 detection.
Verified PD-L1 Reactivity: Human WB, FACS, ELISA, IF Host: Goat Polyclonal unconjugated
PD-L1 Reactivity: Human WB, FACS, IHC, ELISA, IF Host: Mouse Monoclonal 9B5F4 unconjugated
PD-L1 Reactivity: Human FACS, IHC, ELISA Host: Mouse Monoclonal 6D9A2 unconjugated
PD-L1 Antibodies by Grade
Find PD-L1 Antibodies with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
PD-L1 Antibodies by Reactivity
Find PD-L1 Antibodies for a variety of species such as anti-Human PD-L1, anti-Mouse PD-L1, anti-Rat PD-L1. The species listed below are among those available. Click on a link to go to the corresponding products.
PD-L1 Antibodies by Host
Find PD-L1 Antibodies with a specific Host. The Host listed below are among those available. Click on a link to go to the corresponding products.
PD-L1 Antibodies by Clonality
Find available monoclonal or polyclonal PD-L1 Antibodies. Click on a link to go to the corresponding products.
PD-L1 Antibodies by Fragment
Find PD-L1 Antibodies with a specific Fragment. The Fragment listed below are among those available. Click on a link to go to the corresponding products.
Popular PD-L1 Antibodies
- (1)
- (11)
- (9)
- (6)
- (10)
- (5)
- (5)
- (4)
- (4)
- (7)
- (3)
- (4)
- (3)
- (3)
- (3)
- (3)
- (4)
Latest Publications for our PD-L1 Antibodies
: "Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin." in: PLoS ONE, Vol. 16, Issue 1, pp. e0245581, (2021) (PubMed).: "Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma." in: Frontiers in oncology, Vol. 11, pp. 757919, (2021) (PubMed).
: "Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder." in: Journal of clinical medicine, Vol. 9, Issue 5, (2020) (PubMed).
: "NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer." in: Nature communications, Vol. 11, Issue 1, pp. 1669, (2020) (PubMed).
: "Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer." in: PLoS ONE, Vol. 15, Issue 3, pp. e0230449, (2020) (PubMed).
: "MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma." in: Aging, Vol. 12, Issue 2, pp. 1213-1236, (2020) (PubMed).
: "Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. ..." in: Cancer immunology research, Vol. 7, Issue 5, pp. 841-852, (2019) (PubMed).
: "Autophagy inhibition enhances PD-L1 expression in gastric cancer." in: Journal of experimental & clinical cancer research : CR, Vol. 38, Issue 1, pp. 140, (2019) (PubMed).
: "Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy." in: PLoS ONE, Vol. 14, Issue 5, pp. e0215990, (2019) (PubMed).
: "Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 308, pp. 29-43, (2019) (PubMed).
Aliases for PD-L1 Antibodies
CD274 molecule (CD274) AntibodiesCD274 antigen (Cd274) Antibodies
programmed cell death 1 ligand 2 (PDCD1LG2) Antibodies
CD274 molecule (Cd274) Antibodies
A530045L16Rik Antibodies
B7-H Antibodies
B7H1 Antibodies
B7h1 Antibodies
PD-L1 Antibodies
PDCD1L1 Antibodies
Pdcd1l1 Antibodies
PDCD1LG1 Antibodies
Pdcd1lg1 Antibodies
PDL1 Antibodies
Pdl1 Antibodies
RGD1566211 Antibodies
Did you look for something else?
- PD-1 Antibodies
- PCYT2 Antibodies
- PCYOX1L Antibodies
- PCYOX1 Antibodies
- PCTP Antibodies
- PCSK9 Antibodies
- PCSK7 Antibodies
- PCSK6 Antibodies
- PCSK5 Antibodies
- PCSK4 Antibodies
- PCSK2 Antibodies
- PCSK1N Antibodies
- PCSK1 Antibodies
- PCP4 Antibodies
- Pcp2 Antibodies
- PCOTH Antibodies
- PCOLCE2 Antibodies
- PCOLCE Antibodies
- PCNXL2 Antibodies
- PCNT Antibodies
- PDAP1 Antibodies
- PDCD11 Antibodies
- PDCD1LG2 Antibodies
- PDCD2 Antibodies
- PDCD2L Antibodies
- PDCD5 Antibodies
- PDCD6 Antibodies
- PDCD7 Antibodies
- PDCL2 Antibodies
- PDCL3 Antibodies
- PDE10A Antibodies
- PDE11A Antibodies
- PDE12 Antibodies
- PDE1A Antibodies
- PDE1B Antibodies
- PDE1C Antibodies
- PDE2A Antibodies
- PDE3A Antibodies
- PDE3B Antibodies
- PDE4A Antibodies
